JEEIX | PGIUX | JEEIX / PGIUX | |
Total Expense Ratio | 0.96 | 0.98 | 98% |
Annual Report Gross Expense Ratio | 0.97 | 0.98 | 99% |
Fund Existence | 12 years | 17 years | - |
Gain YTD | 18.411 | 12.069 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 100000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 678M | 154M | 440% |
Annual Yield % from dividends | 2.31 | 2.08 | 111% |
Returns for 1 year | 13.34 | 5.66 | 236% |
Returns for 3 years | 39.36 | 4.06 | 970% |
Returns for 5 years | 49.52 | 15.89 | 312% |
Returns for 10 years | 94.05 | 32.59 | 289% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 13.30 | 0.22 | +1.68% |
AlphaCentric Life Sciences & Hlthcare A | |||
CLARX | 8.19 | 0.06 | +0.74% |
NYLI CBRE Real Estate Class A | |||
BGATX | 18.62 | N/A | N/A |
Baillie Gifford Global Alpha Equities 2 | |||
SVALX | 6.46 | N/A | N/A |
Federated Hermes Strategic Value Div R6 | |||
NSRIX | 25.51 | -0.08 | -0.31% |
Northern World Selection Index I |